Access to some HIV drugs is increasing in Thailand because of the country’s decision to issue compulsory licenses for certain meds, according to Winai Sawasdiworn, deputy secretary-general of the National Health Security Office, The Bangkok Post reports.

You may recall that, early last year, the Thai government issued a compulsory license to make a lower-cost version of Abbott’s Kaletra AIDS drug. The drugmaker later offered to sell an updated version called Aluvia at a reduced price, but only if Thailand agreed not to allow generics to be sold. But talks failed and Thailand last fall allowed India’s Matrix Laboratories to begin sales.

According to Winai, the first batch of generic Kaletra was delivered to state hospitals three month ago, and a shipment of generic Efavirenz, a Merck HIV drug for which a compulsory license was also issued, has been imported from India as well, according to the Post. His remarks were made in response to criticism from HIV advocates who charge Thailand has been slow to distribute the drugs.